Cohen & Steers Inc(CNS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 21.84 | EPS (ttm) | 3.26 | Insider Own | 45.99% | Shs Outstand | 51.4M | Perf Week | 4.01% |
| Market Cap | 3.66B | Forward P/E | 19.84 | EPS next Y | 6.54% | Insider Trans | -0.07% | Shs Float | 27.8M | Perf Month | -4.12% |
| Enterprise Value | 3.51B | PEG | 1.76 | EPS next Q | 0.88 | Inst Own | 57.2% | Short Float | 6.06% | Perf Quarter | -13.7% |
| Income | 0.17B | P/S | 5.83 | EPS this Y | 8.9% | Inst Trans | 9.52% | Short Ratio | 5.92 | Perf Half Y | 4.39% |
| Sales | 0.63B | P/B | 6.21 | EPS next 5Y | 11.3% | ROA | 20.38% | Short Interest | 1.68M | Perf YTD | 13.32% |
| Book/sh | 11.46 | P/C | 9.43 | EPS past 3/5Y | -5.01% 13.58% | ROE | 30.11% | 52W High | -17.81% ($86.56) | Perf Year | -0.28% |
| Cash/sh | 7.54 | P/FCF | 18.99 | Sales past 3/5Y | -0.15% 6.24% | ROIC | 23.33% | 52W Low | 21.84% ($58.39) | Perf 3Y | 38.38% |
| Dividend Est. | $2.68 (3.77%) | EV/EBITDA | 16.23 | EPS Y/Y TTM | 2.05% | Gross Margin | 85.44% | Volatility(W/M) | 3.19% 3.23% | Perf 5Y | -23.36% |
| Dividend TTM | 2.63 | EV/Sales | 5.6 | Sales Y/Y TTM | 13.3% | Oper. Margin | 32.82% | ATR (14) | 2.36 | Perf 10Y | 124.13% |
| Dividend Ex-Date | 2026/8/10 | Quick Ratio | 5.22 | EPS Q/Q | 0.15% | Profit Margin | 26.91% | RSI (14) | 47.31 | Recom | 2.67 |
| Dividend Gr. 3/5Y | 4.07% 9.71% | Current Ratio | 5.22 | Sales Q/Q | 10.16% | SMA20 | 0.48% ($70.8) | Beta | 1.19 | Target Price | $67.5 |
| Payout | 83.4% | Debt/Eq | 0.23 | Earnings | 2026/10/15 | SMA50 | -5.25% ($75.08) | Rel Volume | 0.72 | Prev Close | $71 |
| Employees | 424 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | - 0.83% | SMA200 | -1.12% ($71.95) | Avg Volume(3M) | 0.28M | Price | $71.14 |
| IPO | 2004/8/13 | Option/Short | Yes/Yes | Trades | 4115 | Volume | 204,519 | Change | 0.2% |
💰 A global asset management firm specializing in real-asset investing. The company focuses on managing real-asset and income-generating assets such as REITs, infrastructure, commodities, and preferred stocks, generating fee revenue based on assets under management. It is a specialized asset manager in the real-asset space.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
Traded less than usual. That is 72% of its average volume.
CNS makes money exceptionally well
Of every $100 in sales, $32.82 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.9% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,184. Peers typically go for $1,779. It is about in line with its own 5-year average.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -23.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 3.77% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 57.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #35 of 134 in the industry
Based on market cap of $4B.
CNS#35 Cohen & Steers Inc $4B PER 21.8 
HLNE#36 Hamilton Lane Inc $4B PER 12.4 
STEP#37 StepStone Group Inc $3B PER - 
AAMI#38 Acadian Asset Management Inc $3B PER 33.0 
ASST#39 Strive Inc $3B PER - 
FAQ
What kind of company is CNS?
CNS belongs to the Financial sector and operates in the Asset Management industry.
What is the market cap of CNS?
The market cap of CNS is approximately $3.7B, ranking 1,582 within its sector.
Does CNS pay dividends?
CNS has a dividend yield of approximately 3.77%, with an annual dividend of $2.68.
What is the P/E ratio of CNS?
CNS has a P/E ratio of approximately 21.8x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CNS?
CNS has recorded a 52-week high of $86.56 and a low of $58.39.
